AU4694999A - Use of thiazolidinedione derivatives for the treatment or prevention of cataracts - Google Patents

Use of thiazolidinedione derivatives for the treatment or prevention of cataracts

Info

Publication number
AU4694999A
AU4694999A AU46949/99A AU4694999A AU4694999A AU 4694999 A AU4694999 A AU 4694999A AU 46949/99 A AU46949/99 A AU 46949/99A AU 4694999 A AU4694999 A AU 4694999A AU 4694999 A AU4694999 A AU 4694999A
Authority
AU
Australia
Prior art keywords
cataracts
prevention
treatment
thiazolidinedione derivatives
thiazolidinedione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46949/99A
Inventor
John Hardwick Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Priority claimed from PCT/US1999/013810 external-priority patent/WO2000007582A2/en
Publication of AU4694999A publication Critical patent/AU4694999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU46949/99A 1998-08-06 1999-06-18 Use of thiazolidinedione derivatives for the treatment or prevention of cataracts Abandoned AU4694999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9551598P 1998-08-06 1998-08-06
US60095518 1998-08-06
PCT/US1999/013810 WO2000007582A2 (en) 1998-08-06 1999-06-18 Use of thiazolidinedione derivatives for the treatment or prevention of cataracts

Publications (1)

Publication Number Publication Date
AU4694999A true AU4694999A (en) 2000-02-28

Family

ID=22252362

Family Applications (2)

Application Number Title Priority Date Filing Date
AU46949/99A Abandoned AU4694999A (en) 1998-08-06 1999-06-18 Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
AU55476/99A Abandoned AU5547699A (en) 1998-08-06 1999-08-03 Fungicidal fused bicyclic heterocycles

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU55476/99A Abandoned AU5547699A (en) 1998-08-06 1999-08-03 Fungicidal fused bicyclic heterocycles

Country Status (2)

Country Link
AU (2) AU4694999A (en)
WO (1) WO2000008026A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1578781A (en) * 2001-09-26 2005-02-09 拜尔药品公司 1,8 naphthyridine derivatives and their use to treat diabetes and related disorders
JP4975739B2 (en) * 2005-05-17 2012-07-11 シェーリング コーポレイション Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
WO2009094560A2 (en) * 2008-01-24 2009-07-30 Semafore Pharmaceuticals, Inc. Thienopyranones as kinase inhibitors
US20110201501A1 (en) * 2008-10-29 2011-08-18 Basf Se Substituted Pyridines Having a Herbicidal Effect
WO2011051212A1 (en) * 2009-10-28 2011-05-05 Basf Se Use of heteroaromatic compounds as herbicides
JP5765371B2 (en) * 2013-06-14 2015-08-19 宇部興産株式会社 Heterocyclic oligomer compound having a pentafluorosulfanyl group
US10472326B2 (en) * 2014-04-03 2019-11-12 Helmholtz-Zentrum für Infektionsforschung GmbH PQSR modulators
EP3133065A1 (en) 2015-08-21 2017-02-22 Merck Patent GmbH Compounds for optically active devices
CN106810560B (en) * 2016-12-23 2019-03-01 天津科技大学 A kind of synthetic method of 8- azepine cumarin and its application in anti-tumor drug
WO2018140730A1 (en) * 2017-01-27 2018-08-02 Signalrx Pharmaceuticals, Inc. Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors
EP3363786A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Compounds for optically active devices
EP3363793A1 (en) 2017-02-15 2018-08-22 Merck Patent GmbH Hydrophobic compounds for optically active devices
WO2020023340A1 (en) * 2018-07-23 2020-01-30 Signalrx Pharmaceuticals, Inc. Single molecule compounds providing multi-target inhibition of btk and other proteins and methods of use thereof
KR20230012616A (en) 2020-05-20 2023-01-26 에이엠오 아일랜드 Azacoumarin and azathiocoumarin derivatives for use in optically active devices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4103257A (en) * 1976-05-25 1978-07-25 The United States Of America As Represented By The United States Department Of Energy Azaquinolone dye lasers
DE4308014A1 (en) * 1993-03-13 1994-09-15 Hoechst Schering Agrevo Gmbh Condensed nitrogen heterocycles, processes for their preparation and their use as pesticides and fungicides
JPH07126268A (en) * 1993-10-29 1995-05-16 Otsuka Pharmaceut Factory Inc 1,8-naphthyridine derivative
DE69613139T2 (en) * 1995-10-13 2001-09-13 Aventis Cropscience Uk Ltd., Hauxton HETEROCYCLIC FUNGICIDES
EP0949262B1 (en) * 1996-12-25 2001-08-22 Zenyaku Kogyo Kabushikikaisha Cephem compounds
WO1998047899A1 (en) * 1997-04-24 1998-10-29 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases

Also Published As

Publication number Publication date
WO2000008026A2 (en) 2000-02-17
WO2000008026A3 (en) 2000-08-10
AU5547699A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
AUPP609198A0 (en) Use of non-peptidyl compounds for the treatment of insulin related ailments
AU2935200A (en) Compounds for the treatment of obesity
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
AU2002364300A1 (en) Polymer derivatives for the treatment of metals
AU4694999A (en) Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
ZA9811629B (en) The use of MMP inhibitors for the treatment of ocular angiogenesis.
AU5038299A (en) Process for the biocidal treatment of surfaces
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
AU6330999A (en) Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU2002300593A1 (en) Process for the preparation of thiazolidinedione derivatives
AU2001253165A1 (en) Use of fluorocarbons for the prevention of surgical adhesions
AU1878201A (en) Composition for the treatment of damaged tissue
AU2021601A (en) Composition for the treatment of dandruff
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU9278598A (en) Use of azole derivatives for the treatment of inflammatory skin conditions
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU6331099A (en) Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
AU2182800A (en) Use of inhibitors of gag synthesis for the treatment of corneal haze
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU3501100A (en) Synergistic combination for treatment of viral-mediated diseases
AU1022501A (en) Use of compositions for the caring treatment of the skin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase